Dr. Ali M. Hama Amin, MD

Dr. Hama Amin practices at Carilion Roanoke Memorial Hospital in Roanoke, Virginia, part of Carilion Clinic.

Dr. Hama Amin's NPI, 1841467735, was assigned on May 11, 2008. Dr. Hama Amin holds U.S. Virgin Islands license 0101246989.

Dr. Hama Amin's primary practice is Carilion Roanoke Memorial Hospital, at 1906 Belleview Avenue, SE, Roanoke, VA 24014 in Roanoke City. The practice phone is (540) 981-7000.

Dr. Hama Amin's primary practice is Carilion Roanoke Memorial Hospital in Roanoke, Virginia, part of Carilion Clinic. Dr. Hama Amin is also affiliated with Carilion New River Valley Medical Center. The medical group on file is Carilion Clinic. Dmand AI also links Dr. Hama Amin to 3 more hospitals, 3 medical groups, 2 group practices and clinics and 1 rural health clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hama Amin practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Hama Amin's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Hama Amin's licenses on file in 4 states: U.S. Virgin Islands, Massachusetts, Virginia and West Virginia.

CMS data shows 6,894 Medicare services from Dr. Hama Amin across 39 procedure codes in 2024, for 4,091 Medicare patients. Medicare paid $168,793 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 4,091 Medicare patients who saw Dr. Hama Amin in 2024. The largest group is 75 to 84, with 1,650 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hama Amin's median patient age at 73, with 53% women.

In 2024, Dr. Hama Amin wrote 5,936 Medicare Part D claims for 763 patients. 82% of them were for generic drugs. CMS names the drug for 5,708 of them, across 54 drugs with 11 or more claims each, at $1,425,965 in total drug cost. In 2023, CMS named 5,259 claims across 48 drugs.

Dr. Hama Amin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 41 general payments to Dr. Hama Amin from 11 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 59% of the total. Boston Scientific Corporation paid the most, $2,078. It also lists 1 research payment totaling $12 in 2017.